Swiss-based biopharmaceutical company Inthera Bioscience has completed a series A financing round led by Merck Ventures to raise Sfr10.5m ($10.53m).

Aglaia BioMedical Ventures, Novo Seeds and other private investors also participated in the round.

US-based biotechnology company Sea Lane Biotechnologies has sold its entire antibody and engineered protein technology portfolio to i2 Pharmaceuticals, a biopharmaceutical company also based in the US.

The portfolio includes human antibody libraries, human b-cell derived antibodies and surrobodies, which enable facile creation of bispecific therapeutic agents from arrays of monospecific agents.

"Chinese biotechnology company InventisBio has completed a series B venture financing round to raise $19m."

Chinese biotechnology company InventisBio has completed a series B venture financing round to raise $19m.

The proceeds will be used to advance the company’s product development through phase one clinical trials.

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

Rigel Pharmaceuticals intends to raise $40m in gross proceeds through a public offering of shares of its common stock.

The US-based pharmaceutical company intends to use the proceeds for general corporate purposes.